TABLE 1.

Patient Demographic Data

Patient	Age (y)	Injected dose (MBq)	Mass (μg)	ER/PR/HER2	Tumor T/N	Tumor SUV	DVR
Dynamic patients
1	59	359	5.38	−/−/−/	1.9	3.4	2.4
2	39	281	0.84	+/+/−/, +/+/−/*	2.3, 2.5*	3.0, 3.2*	1.9, 2.7
3	59	222	3.41	−/−/−/	1.9	1.5	1.4
4	32	178	0.83	+/−/−/	1.1	3.9	1.4
5	57	366	0.53	+/+/−/, +/+/−/*	3.5, 2.8*	3.4, 2.7*	3.7, 2.8
6	58	148	1.91	+/+/−/	1.2	2.1	1.1
7	71	366	0.56	+/+/−/	2.2	2.9	2.0
8	58	370	0.34	+/+/−/	1.7	1.2	1.6
Dosimetry patients
1	49	89	1.39	+/+/−/	2.4	1.2	Not applicable
2	52	185	1.87	+/+/−/	1.9	2.3	Not applicable
3	64	370	2.67	+/+/−/	1.8	2.4	Not applicable
4	49	104	0.83	−/−/−/	1.5	1.6	Not applicable
5	53	329	0.75	−/−/−/	1.5	1.2	Not applicable
6	47	270	1.32	−/−/−/	1.2	0.5	Not applicable
7	68	359	0.90	+/+/−/	1.5	1.2	Not applicable
8	64	370	0.31	+/+/−/	4.0	4.4	Not applicable
9	44	215	0.90	+/+/−/	2.6	1.8	Not applicable
10	62	352	0.54	+/+/−/	4.0	3.2	Not applicable
11	55	315	0.76	+/+/−/	3.2	1.9	Not applicable
12	49	259	0.70	+/+/−/	3.8	2.3	Not applicable

^*Second breast cancer in patients with 2 breast cancers.